# A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan

> **NCT06864585** · — · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 59 (estimated)

## Conditions studied

- Infectious Diseases

## Interventions

- **DRUG:** Avibactam sodium/Ceftazidime hydrate

## Key facts

- **NCT ID:** NCT06864585
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2029-03-30
- **Final completion:** 2029-03-30
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864585, "A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06864585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*